Biolife Sciences Inc
OTC:BLFE

Watchlist Manager
Biolife Sciences Inc Logo
Biolife Sciences Inc
OTC:BLFE
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $4.8k

Intrinsic Value

BLFE latest financial reports are more than 10 years old.
BLFE doesn't have a meaningful market cap.

The intrinsic value for Biolife Sciences Inc (BLFE) under the Base Case is 0.0003 USD. Compared with the current market price of 0.0001 USD, the stock appears Undervalued by 70% .

Intrinsic value calculated using DCF
$0.0003

Do our valuations actually work? See backtest results .

BLFE Intrinsic Value
$0.0003
Undervaluation 70%
Intrinsic Value
Price $0.0001
Monitor BLFE
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $0
Get notified when the price drops into your buy zone
Intrinsic Value $0
Margin of Safety 20% $0
Current Price $0
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about BLFE?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BLFE valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Biolife Sciences Inc.

Explain Valuation
Alternatives to BLFE

Fundamental Analysis

Financials

Revenue & Expenses Breakdown
Biolife Sciences Inc

Efficiency

Earnings Waterfall
Biolife Sciences Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one BLFE stock?

The intrinsic value for Biolife Sciences Inc (BLFE) under the Base Case is 0.0003 USD.

Is BLFE stock undervalued or overvalued?

Compared with the current market price of 0.0001 USD, the stock appears Undervalued by 70% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett